Replies to post #16617 on Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

Honestly, I just don't see that scenario. Holding up the approval of MNTA 40 mg thrice/week formula because Mylan submitted first doesn't make any sense to my way of thinking, but that's me. Perhaps its just the inefficiencies of the FDA that has this process going slower than most of us expected. Like watching paint dry.??